# PYCARD

## Overview
PYCARD is a gene that encodes the protein ASC (Apoptosis-associated Speck-like protein containing a CARD), which is integral to the regulation of apoptosis and inflammation. The ASC protein is characterized by its two domains: the N-terminal pyrin domain (PYD) and the C-terminal caspase recruitment domain (CARD), classifying it as an adaptor protein involved in the assembly of inflammasomes. These domains facilitate interactions with other proteins, playing a pivotal role in the innate immune response by activating caspase-1 and promoting the maturation of pro-inflammatory cytokines such as IL-1β and IL-18 (Borrego2022Pycard; Dunn2015PYCARD). PYCARD is also implicated in apoptosis, operating within both intrinsic and extrinsic pathways, and is subject to epigenetic regulation (Miao2019A). The protein's activity is primarily observed in the cytoplasm and nucleus of immune cells, where it forms ASC specks, indicating inflammasome activation (Borrego2022Pycard). The gene's expression and function are influenced by various factors, including methylation and interactions with long noncoding RNAs, highlighting its significance in maintaining cellular homeostasis and responding to inflammatory stimuli (Miao2019A).

## Structure
The PYCARD gene encodes a protein known as ASC, which is involved in apoptosis and inflammation. The protein is composed of two main domains: an N-terminal pyrin domain (PYD) and a C-terminal caspase recruitment domain (CARD). These domains are structurally independent six-helix bundle motifs connected by a 23-residue proline and glycine-rich linker domain (Dunn2015PYCARD). The PYD domain, also referred to as the DAPIN or PAAD domain, is involved in binding other PYD-containing proteins and is part of the death domain-fold superfamily (Dunn2015PYCARD; Martinon2001The). The CARD domain features six to seven antiparallel alpha helices with a hydrophobic core and charged outer face, mediating interactions between adaptor proteins in apoptosis and inflammation (Dunn2015PYCARD).

PYCARD has four isoforms, each with distinct functions related to the inflammasome, with some isoforms activating and others inhibiting inflammasome activity (Dunn2015PYCARD). The protein can form oligomers, contributing to its quaternary structure, and its expression is regulated by methylation of its CpG island (Dunn2015PYCARD). The PAAD domain is implicated in the oligomerization of proteins like ASC, suggesting its role in apoptotic and inflammatory pathways (Liu2003Homology).

## Function
The PYCARD gene encodes a protein known as ASC (Apoptosis-associated Speck-like protein containing a CARD), which plays a crucial role in the regulation of inflammasome activity and apoptosis in healthy human cells. PYCARD contains a PYD (Pyrin domain) and a CARD (Caspase activation and recruitment domain), which facilitate the assembly of inflammasomes, multiprotein complexes that are essential for the innate immune response (Borrego2022Pycard). These inflammasomes activate caspase-1, leading to the cleavage and maturation of pro-inflammatory cytokines such as IL-1β and IL-18, which are then released to mediate inflammatory responses (Borrego2022Pycard). 

In addition to its role in inflammation, PYCARD is involved in apoptosis, a form of programmed cell death. It operates in both intrinsic and extrinsic cell death pathways and is subject to epigenetic regulation, which can be mediated by long noncoding RNAs such as PYCARD-AS1 (Miao2019A). PYCARD is primarily active in the cytoplasm and nucleus of immune cells, where it forms ASC specks, macromolecular structures that indicate inflammasome activation (Borrego2022Pycard). These processes are critical for maintaining cellular homeostasis and responding to infections or inflammatory stimuli.

## Clinical Significance
Mutations and alterations in the PYCARD gene, also known as ASC, have significant clinical implications. In chronic obstructive pulmonary disease (COPD), PYCARD is identified as a crucial gene related to panoptosis, immune response, and inflammation. Its expression is significantly different between low and high expression groups, and it is associated with processes like cell death and immune system processes. PYCARD's role in inflammation and immune signaling pathways suggests its potential as a therapeutic target in COPD (Shi2024Identification).

PYCARD gene polymorphisms are linked to increased susceptibility to periodontal disease and coronary heart disease (CHD). Specific polymorphisms, such as PYCARD C/T and A/G, are associated with a higher risk of these diseases, potentially through pathways involving pyroptosis, a form of programmed cell death (Daily2024PYCARD).

In cancer, the methylation status of the PYCARD promoter is associated with clinical outcomes. Aberrant hypermethylation leads to gene silencing in various cancers, including non-small cell lung cancer (NSCLC), and is linked with decreased overall survival and tumor grade (Šutić2019Promoter). Additionally, PYCARD mutations can modulate inflammasome activation, affecting IL-1β production, which is crucial in inflammatory responses and cancer progression (Borrego2022Pycard).

## Interactions
PYCARD, also known as ASC, is a key adaptor protein involved in the formation of inflammasomes, which are crucial for innate immune responses. It contains both a pyrin domain (PYD) and a caspase-recruitment domain (CARD), facilitating interactions with various proteins. PYCARD interacts with NOD-like receptors such as NLRP3, linking them to caspase-1 through its PYD and CARD domains. This interaction is essential for the cleavage of pro-inflammatory cytokines like pro-IL1β and pro-IL18 into their active forms, which are then released during inflammasome activation (Borrego2022Pycard).

PYCARD also participates in the formation of ASC specks, macromolecular structures formed through PYD-dependent oligomerization, serving as a readout for inflammasome activation. Specific amino acid residues in the PYD domain are crucial for ASC speck formation, and mutations can affect this process (Borrego2022Pycard). Additionally, PYCARD interacts with proteins involved in apoptosis regulation, such as caspase-8 and caspase-9, promoting apoptosis through these pathways (Xu2024Identification).

PYCARD's interactions extend to nucleic acids, as it is involved in RNA-protein interactions. The PYCARD-AS1 RNA associates with proteins like DNMT1 and G9a, highlighting its role in coordinating epigenetic and translational regulation (Miao2019A).


## References


[1. (Miao2019A) Hui Miao, Linlin Wang, Haomiao Zhan, Jiangshan Dai, Yanbo Chang, Fan Wu, Tao Liu, Zhongyu Liu, Chunfang Gao, Ling Li, and Xu Song. A long noncoding rna distributed in both nucleus and cytoplasm operates in the pycard-regulated apoptosis by coordinating the epigenetic and translational regulation. PLOS Genetics, 15(5):e1008144, May 2019. URL: http://dx.doi.org/10.1371/journal.pgen.1008144, doi:10.1371/journal.pgen.1008144. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1008144)

[2. (Daily2024PYCARD) Zina Ali Daily, Batool Hassan Al-Ghurabi, and Ahmed Makki Al-Qarakhli. Pycard gene polymorphisms and susceptibility to periodontal and coronary heart diseases. Journal of Medicine and Life, 17(2):195–200, February 2024. URL: http://dx.doi.org/10.25122/jml-2023-0263, doi:10.25122/jml-2023-0263. This article has 0 citations.](https://doi.org/10.25122/jml-2023-0263)

[3. (Dunn2015PYCARD) JH Dunn and M Fujita. Pycard (pyd and card domain containing). Atlas of Genetics and Cytogenetics in Oncology and Haematology, March 2015. URL: http://dx.doi.org/10.4267/2042/56440, doi:10.4267/2042/56440. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.4267/2042/56440)

[4. (Shi2024Identification) Rui Shi, Renwen Liang, Fang Wang, Lueli Wang, Wuyi Zidai, Jie Zhang, Luo Min, Xiaohua Du, Shibo Sun, Chuang Xiao, Chaozhong Li, Xuewu Liang, Alex F. Chen, and Weimin Yang. Identification and experimental validation of pycard as a crucial panoptosis-related gene for immune response and inflammation in copd. Apoptosis, April 2024. URL: http://dx.doi.org/10.1007/s10495-024-01961-6, doi:10.1007/s10495-024-01961-6. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10495-024-01961-6)

[5. (Martinon2001The) Fabio Martinon, Kay Hofmann‡, and Jürg Tschopp. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Current Biology, 11(4):R118–R120, February 2001. URL: http://dx.doi.org/10.1016/s0960-9822(01)00056-2, doi:10.1016/s0960-9822(01)00056-2. This article has 198 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0960-9822(01)00056-2)

[6. (Xu2024Identification) Yan Xu, Jingqi Hua, Hongliang Que, Tengyue Zeng, Quan Li, Junpeng Deng, and Jianjun Xie. Identification of panoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma. BMC Cancer, March 2024. URL: http://dx.doi.org/10.1186/s12885-024-12067-2, doi:10.1186/s12885-024-12067-2. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-024-12067-2)

[7. (Borrego2022Pycard) Andrea Borrego, Francesca Colombo, Jean Gabriel de Souza, José Ricardo Jensen, Alice Dassano, Rocco Piazza, Barbara Anaís Rodrigues dos Santos, Orlando Garcia Ribeiro, Marcelo De Franco, Wafa Hanna Koury Cabrera, Marcelo Yudi Icimoto, Nancy Starobinas, Geraldo Magalhães, Leticia Figueiredo Monteleone, Silas Fernandes Eto, Carlos DeOcesano-Pereira, Mauricio Barbugiani Goldfeder, Kerly Fernanda Mesquita Pasqualoto, Tommaso A. Dragani, and Olga Célia Martinez Ibañez. Pycard and bc017158 candidate genes of irm1 locus modulate inflammasome activation for il-1β production. Frontiers in Immunology, June 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.899569, doi:10.3389/fimmu.2022.899569. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.899569)

[8. (Šutić2019Promoter) Maja Šutić, Antje Motzek, Gordana Bubanović, Matthias Linke, Ivan Sabol, Oliver Vugrek, Petar Ozretić, Luka Brčić, Sven Seiwerth, Željko Debeljak, Antonija Jakovčević, Zoran Janevski, Dinko Stančić-Rokotov, Andrea Vukić-Dugac, Marko Jakopović, Miroslav Samaržija, Ulrich Zechner, and Jelena Knežević. Promoter methylation status of asc/tms1/pycard is associated with decreased overall survival and tnm status in patients with early stage non-small cell lung cancer (nsclc). Translational Lung Cancer Research, 8(6):1000–1015, December 2019. URL: http://dx.doi.org/10.21037/tlcr.2019.12.08, doi:10.21037/tlcr.2019.12.08. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tlcr.2019.12.08)

[9. (Liu2003Homology) Tong Liu, Ana Rojas, Yuzhen Ye, and Adam Godzik. Homology modeling provides insights into the binding mode of the paad/dapin/pyrin domain, a fourth member of the card/dd/ded domain family. Protein Science, 12(9):1872–1881, September 2003. URL: http://dx.doi.org/10.1110/ps.0359603, doi:10.1110/ps.0359603. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1110/ps.0359603)